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Abstract  22 
Background & Aims: Malnutrition has an adverse effect on clinical outcomes and 23 
frail older people may be at greater risk of malnutrition. The purpose and aims of this 24 
study was to investigate the relationship between markers of malnutrition risk and 25 
clinical outcomes in a cohort of frail older hospital patients.  26 
Methods: 78 frail older hospital patients had the following measurements recorded; 27 
length of stay (LOS), time to medical fitness for discharge (TMFFD), body mass 28 
index (BMI), malnutrition universal screening tool (MUST) and mini-nutritional 29 
assessment short-form (MNA-SF) scores, blood urea, C-reactive protein (CRP), 30 
albumin, CRP-albumin ratio; and bioelectrical impedance assessment (BIA) 31 
measurements (n=66). Patients were grouped by mortality status 12 months post 32 
hospital admission. Grouping by albumin classification was performed (n=66) 33 
whereby, <30 g/l indicated severe malnutrition, 30-34.9, moderate and >35, low. 34 
Receiver-operating characteristic (ROC) curve analysis was performed on variables 35 
as potential predictors of mortality. 36 
Results: After 12 months, 31% (n=24) of patients died. LOS was significantly greater 37 
in this group (25.0±22.9 vs 15.4±12.7d, P<0.05). BMI (23.8±4.9 vs 26.4±5.5kg/m2); 38 
fat mass (FM) (17.2±9.9 vs 25.5±10.5kg), fat mass index (FMI) (9.3±4.1 vs 39 
17.9±2.4kg/m2); and MNA-SF score (6.6±2.4 vs 8.6±2.7) were significantly lower 40 
(P<0.05), and urea significantly higher (11.4±8.7 vs 8.8±4.4mmols/l, P=0.05). 41 
Albumin was typically low across the entire group (30.5±5.9 g/l) and a potential 42 
relationship was identified between albumin and MNA-SF score. MNA-SF, FM, and 43 
FMI were significant predictors of mortality outcome by ROC curve analysis, 44 
whereas MUST was a poor predictor. 45 
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Conclusion: This study highlights a potential relationship between indicators of 46 
malnutrition risk and clinical outcomes in frail older hospital patients which should be 47 
studied in larger cohorts with an aim to improve patient care. 48 
(275 words) 49 
 50 
Keywords: malnutrition, frailty, cachexia, malnutrition universal screening tool 51 
(MUST), mini nutritional assessment (MNA), bioelectrical impedance assessment. 52 
 53 
Introduction  54 
Frail older people may be admitted to hospital wards suffering from a range of acute 55 
and chronic disease/s, with signs and symptoms of physical and/or cognitive frailty 56 
and be on multiple medications. Identifying possible nutritional risk/malnutrition is 57 
important and may affect trajectory of health, morbidity, and mortality1-4. Different 58 
screening methods exist including the ‘malnutrition universal screening tool’ 59 
(MUST)1,5, the ‘mini-nutritional assessment’ (MNA)1,6-8 and the ‘geriatric nutritional 60 
risk index’, (GNRI)9. In the United Kingdom (UK), the MUST is the standard routine 61 
method of screening in all hospital wards and care homes, although in reality there is 62 
no universal gold standard tool4. We showed recently in a cohort of frail older 63 
hospital patients that there is a significant discordance between MUST and ‘MNA-64 
short form’ (MNA-SF) malnutrition screening categorisation10. The MUST 65 
predominantly categorized patients as ‘low risk’ (77%) and MNA-SF predominantly 66 
as ‘at risk’ (46%) and ‘malnourished’ (45%). Reliability assessment found poor 67 
reliability between the screening tools and bioelectrical impedance assessment (BIA) 68 
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assessment was in general agreement with MNA-SF scoring patterns, especially in 69 
male patients. A potential body mass index (BMI) paradox was also highlighted 70 
whereby some patients who were ‘at risk’ or ‘malnourished’ by MNA-SF scores had 71 
normal BMI and depleted/borderline BIA measurements of fat free mass (FFM) / fat 72 
mass (FM) and specifically indices (FFMI and FMI, in kg/m2). Potential reasons for 73 
the observed MUST-MNA-SF discordance include: the MUST uses World Health 74 
Organization (WHO) BMI grading criteria, and there maybe difficulty in obtaining 75 
accurate weight loss information in this patient group. Further, the MNA-SF has 76 
additional screening questions on ‘mobility’ and ‘neuropsychological problems’ which 77 
would create a tendency to score worse in a frail older patient group.   78 
An important area to address which overlaps malnutrition is ‘cachexia’/’cachexia-79 
risk’, as acute and chronic illness has a typical effect upon food intake (anorexia) and 80 
metabolism (e.g. hypermetabolism and raised protein breakdown), principally 81 
through actions of circulating proinflammatory cytokines11,12. Other measurable 82 
domains of nutritional status which are sensitive to malnutrition and inflammation 83 
include important blood markers such as albumin, which is utilised in the GNRI9, and 84 
is a well known prognostic marker13-16. C-reactive protein (CRP) is another routine 85 
blood marker indicating inflammatory status and has known prognostic potential17,18. 86 
Recently, the CRP/albumin ratio has been used to better predict mortality risk in 87 
septic patients19.  88 
A better understanding of the relationship between malnutrition risk screening, body 89 
composition assessment and blood markers in heterogeneous groups of frail older 90 
hospital patients on clinical outcomes may improve coordinated hospital nutritional 91 
care in the UK. 92 
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This study was undertaken in a heterogeneous group of frail older adults admitted to 93 
wards specialising in elder care in the UK. We examined outcome of hospital 94 
admission, length of stay (LOS), time to medical fitness to discharge (TMFFD) and 95 
mortality at 12 months post admission and related them to inpatient measurements 96 
of MUST, MNA-SF and BIA. Further, examination was made of routine blood 97 
markers, urea, albumin, CRP, and the CRP/albumin ratio to investigate their 98 
importance in relation to malnutrition risk and outcomes.  99 
(497 words) 100 
 101 
Methods  102 
Participants and study design 103 
This cohort study was undertaken between September 2012 and May 2013 and 104 
recruits were from a purposive sampling from admissions to two hospital wards in 105 
Lincoln, UK specializing in care of frail older patients10. Full ethical approval was 106 
obtained from NHS Leicester, East Midlands Research Ethics Committee (ref: 107 
12/EM/0186) prior to study commencement, ethical guidelines followed and informed 108 
consent sought from all patients. Exclusion criteria from the study were: patients 109 
unable or unwilling to give informed consent and patients who were nil by mouth or 110 
tube fed. BIA measures were contraindicated in patients with defibrillation or cardiac 111 
pacemaker devices. The aim was to recruit 100-150 patients in-line with other similar 112 
studies; however the exclusion criterion of ability to consent and designated study 113 
time restraints dictated the current number. Patients were followed from admission to 114 
12 months post admission with outcomes recorded including: TMFFD, LOS in 115 
6 
 
hospital (days), and deaths at 12 months. Blood measurements were also recorded 116 
where available. 117 
Nutritional assessment 118 
MUST tool and MNA-SF® screening 119 
MUST and MNA-SF® screening was performed as described previously10, whereby 120 
screening scores were converted into categories for nutritional status using MUST 121 
and MNA-SF® scoring criteria either ‘low risk’/’normal’(0 points-MUST, 12-14 MNA-122 
SF), ‘medium risk/at risk’ (1 point-MUST, 8-11 MNA-SF) and ‘high 123 
risk’/’malnourished’ (≥2 points-MUST, 0-7 MNA-SF). 124 
Anthropometric measurements 125 
Height (m) and weight (kg) measurements were performed as described 126 
previously10. 127 
Bioelectrical impedance measurements 128 
BIA measurements were performed as described previously10, using the Kyle et al20 129 
equation for estimation of FFM (kg) and FM (kg) and index values, FFMI (kg/m2) and 130 
FMI (kg/m2), and compared to reference values21.  131 
Blood markers 132 
Routine blood markers were collected and measured in-line with normal patient care 133 
in hospital. Ethical clearance was obtained to utilise these as part of the research 134 
study. Markers utilised and analysed included; urea, albumin, C-reactive protein 135 
(CRP) and the CRP-albumin ratio. Patients were also classified according to albumin 136 
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level and ‘malnutrition severity’, using an adapted method from paper by Bouillanne 137 
et al9, i.e. <30 g/l: severe; 30-34.9 g/l: moderate; and >35 g/l low+absent combined. 138 
 139 
Data analysis 140 
Data is presented as mean average measurements ± standard deviation (SD) with a 141 
range (minimum-maximum) and [median] values. Data has been grouped into ‘alive’ 142 
and ‘deceased’ at 12 months post admission and where relevant into nutritional 143 
screening categories by albumin. Statistical analysis was performed using IBM 144 
SPSS Statistics, version 21, New York, USA. T-tests and Pearson correlations were 145 
used for normally distributed data and Mann-Whitney-U and Spearman correlations 146 
test for nonparametric data. ANOVA and Bonferronni post-hoc test were performed 147 
on more than two groups of data. Categorical differences were analysed using Chi-148 
squared testing. Receiver-operator characteristic (ROC) curve analysis methods 149 
were performed on raw data of variables to evaluate their predictive performance on 150 
the prediction of mortality outcome in patients22. A P value of < 0.05 was considered 151 
statistically significant. 152 
 153 
Results 154 
Data was recorded for 78 patients and followed up 12 months post admission. Within 155 
patient medical notes, blood markers were available for the following: albumin (n=66 156 
patients), urea (n=76), CRP (n=73), and CRP/albumin ratio (n=65). Patients were 157 
grouped according to mortality status at 12 months and data is presented in Table 1. 158 
LOS and urea measurements were significantly higher in the deceased group; and 159 
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BMI and MNA-SF score significantly lower. Patients had BIA measured (n=66) as 160 
completed previously10 and grouped by mortality status (Table 2). FM and FMI by 161 
BIA were found to be significantly lower in patients who died.  162 
 163 
Table 1. Table to show differences in patients grouped by mortality status, 12 164 
months after hospital admission. Mean ± SD is presented with (minimum-maximum) 165 
and [median] values for comparison. 166 
 Alive Deceased 
N 54 (69%) 24 (31%) 
Males/females 30/24 (56%/44%) 19/5 (79%/21%) 
Age, y 81.7±7.4 (65-93) [83] 83.0±8.8 (62-96) [84] 
TMFFD, d 8.5±7.6 (0-37) [7] 10.4±13.8 (0-66) [6] 
LOS, d 15.4±12.7 (2-68) [10] 25.0±22.9 (6-102) [19]* 
BMI, kg/m2 26.4±5.5 (17.2-45.1) [26.3] 23.8±4.9 (16.6-37.2) [23.3]* 
MUST score 0.4±0.8 (0-4) [0] 0.6±1.1 (0-4) [0] 
MUST – ‘Low risk’ 43 (80%) 17 (71%) 
MUST – ‘Medium risk’ 5 (9%) 2 (8%) 
MUST – ‘High risk’ 6 (11%) 5 (21%) 
MNA-SF score 8.6±2.7 (3-14) [8.5] 6.6±2.4 (2-11) [7]* 
MNA-SF – ‘Normal’ 7 (13%) 0 (0%) 
MNA-SF – ‘At risk’ 26 (50%) 9 (46%) 
MNA-SF – ‘Malnourished’ 21 (37%) 15 (54%) 
Urea (mmols/l) 8.9±4.3 (3.1-21.1) [7.8] 11.4±8.7 (1.7-43.9) [10]* 
CRP (mg/l) 56.1±67.4 (0.6-287) [25] 78.6±73.6 (2.1-221) [44.5] 
Albumin (g/l) 31.0±6.1 (15-43) [31] 29.4±5.2 (20-39) [29] 
CRP-albumin ratio 2.1±2.6 (0.05-11.04) [1] 3.1±2.7 (0.06-9.39) [2.4] 
*significantly different compared to patients alive at 12 months: LOS, (P=0.018); BMI, (P=0.018); MNA-SF, 167 
(P=0.001); Urea, (P=0.05).  168 
 169 
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 170 
Table 2. Comparison of BIA data for FFM and FM and index values (FFMI and FMI 171 
in kg/m2) for patient mortality status, 12 months after hospital admission. Mean ± SD 172 
is presented with (minimum-maximum) and [median] values for comparison. 173 
 174 
*significantly different compared to patient group alive at 12 months: FM, (P=0.005); FMI, (P=0.006). 175 
 176 
 177 
Classification by albumin level 178 
Grouping patients by albumin level as a potential indicator of nutritional status is 179 
shown in Table 3. The relationship of albumin level against MNA-SF score is 180 
depicted in Figure 1 with cut-off points shown. The nonparametric correlation 181 
between albumin and MNA-SF was statistical significant (r=0.025, P=0.046). 182 
 183 
 184 
 185 
 186 
 Alive (n = 48) Deceased (n = 18) 
Males/Females 27/21 (56%/44%) 15/3 (83%/17%) 
FFM, kg 49.4±9.2 (31.7-72.0) [49.6] 51.5±9.7 (37.5-72.7) [50.7] 
FFMI, kg/m2 17.5±2.5 (13.2-23.5) [17.5] 17.9±2.4 (13.5-22.2) [17.8] 
FM, kg 25.5±10.5 (3.4-50.6) [22.5] 17.2±9.9 (3.1-42) [18.1]* 
FMI, kg/m2 9.3±4.1 (1.1-22.5) [8.1] 6.1±3.8 (1.3-16.8) [6.4]* 
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Table 3. Patients grouped by albumin classification of malnutrition status. Mean ± 187 
SD is presented with (minimum-maximum) and [median] values for comparison. 188 
 Plasma albumin & malnutrition status 
 <30 g/l – severe 30-34.9 g/l - moderate >35 g/l – low/absent 
Albumin, g/l 25±3.3 (15-29) [26]* 31.6±1.2 (30-33) [32] 37.5±2.6 (35-43) [37] 
N (%) 28 (42%) 19 (29%) 19 (29%) 
Deaths, N (%) 11 (39%) 6 (32%) 5 (26%) 
TMFFD, d 12.4±13.7 (0-66) [8]*† 8.3±6.2 (1-22) [6.5] 6.5±6.6 (0-26) [4] 
LOS, d 25±21.6 (4-102) [19]*† 17.6±15.4 (2-68) [16] 14.1±9.5 (2-33) [12] 
BMI, kg/m2 24.8±5.2 (17-35.2) [23.2] 27.1±6.2 (18.6-45.1) [26.1] 25.4±5.2 (16.6-33.3) [25.6] 
MUST- ‘Low risk’ 23 (82%) 16 (84%) 14 (74%) 
MUST – ‘Medium 
risk’ 
2 (7%) 2 (11%) 1 (5%) 
MUST – ‘High risk’ 3 (11%) 1 (5%) 4 (21%) 
MNA-SF score 7.0±2.5 (2-11) [7] 8.2±2.4 (3-12) [8] 8.6±3.3 (2-14) [8] 
MNA-SF – ‘Normal’ 0 (0%) 2 (10%) 3 (16%) 
MNA-SF – ‘At risk’ 11 (39%) 11 (58%) 8 (42%) 
MNA-SF – 
‘Malnourished’ 
17 (61%) 6 (32%) 8 (42%) 
Urea, mmols/l 10.7±8.6 (1.7-43.9) [8.0] 9.8±4.4 (3.1-18.5) [9.4] 8.7±4.6 (3.2-19.1) [7.6] 
CRP, mg/l 96.7±80.6 (4-287) [86]* 65.6±71.8 (1.6-232) [45] 29.2±38.1 (2.5-172) [17] 
*†: raw uncorrected data significantly different to >35 g/l albumin group (P<0.05), although after Bonferroni 189 
correction no statistical significance remained. *: Bonferroni corrected data <30 g/l albumin significantly different 190 
to >35 g/l albumin group (P=0.005); and CRP significantly different between all groups (P<0.001).  191 
 192 
 193 
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 194 
Figure 1. The relationship between plasma albumin (g/l) and MNA-SF score in 195 
patients where albumin data was available (n=66). Relevant cut-points indicating 196 
malnutrition are shown for both MNA-SF and albumin. Patients alive at 12 months 197 
depicted with closed circles (n=44) and deceased open circles (n=22). Note overall 198 
group correlation was statistically significant (Spearmans, r = 0.25, P=0.046). In 199 
addition, trend-lines are visible for (1): patients alive and (2): deceased. 200 
 201 
ROC curve analysis  202 
ROC curve analysis was performed on data variables evaluating their relative 203 
performance as mortality predictors and is presented as follows: MNA-SF and MUST 204 
scores, BMI, FM and FMI, Figure 2; and blood markers, urea, CRP, albumin and 205 
CRP-albumin ratio, in Figure 3.  206 
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 207 
 208 
Figure 2. ROC curves for variables: MNA-SF, MUST, BMI, FM and FMI; Statistical 209 
data for area under the curve is presented in Table below graph. Standard error is 210 
under nonparametric assumption and asymptotic significance and 95% confidence 211 
intervals (lower and upper bound) are shown. Null hypothesis: true area = 0.5. 212 
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 213 
 214 
Figure 3. ROC curves for variables: urea, CRP, albumin and the CRP-albumin ratio 215 
(crpValb). Statistical data for area under the curve is presented in Table below 216 
graph. Standard error is under nonparametric assumption and asymptotic 217 
significance and 95% confidence intervals (lower and upper bound) are shown. Null 218 
hypothesis: true area = 0.5. 219 
 220 
Variables found to be significantly different from the reference line indicating that 221 
they are significant predictors of mortality were MNA-SF score, FM, and FMI. BMI 222 
had a trend to significance (P=0.062). MUST was not found to be a significant 223 
predictor of mortality outcome. FFM and FFMI were not included in the presentation 224 
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of data as there was no statistical significance. Blood markers were analysed and 225 
have been presented in Figure 3 as a comparison. None were significantly different 226 
to the reference line however, the CRP-albumin ratio performed numerically better. 227 
However, note the confidence intervals (lower and upper bound) would suggest for 228 
all variables relatively high sampling error which is most likely due to the low patient 229 
number and data set, and high variability in the blood markers. 230 
 231 
Discussion 232 
Previously, we showed a potential discordance between MUST and MNA-SF scoring 233 
in frail older hospital patients10. In this report, we show that 12 months after hospital 234 
admission a total of 31% of the participants had died. Those patients who died had a 235 
significantly longer hospital LOS (P=0.018) and a trend for an increase in TMFFD 236 
(Table 1). The mortality group had a significantly lower MNA-SF score (P=0.001) and 237 
there was a visible discordance in relative balance of MUST, MNA-SF categorisation 238 
between the alive and deceased patients. ROC curve analysis (Figure 2) found that 239 
the MNA-SF was a significant predictor of mortality outcome, whereas MUST was 240 
not. Rasheed and Woods also found that the MNA-SF categorised more people 241 
admitted to hospital as malnourished/at risk of malnutrition than MUST23. They noted 242 
that both tools have relative ability to predict mortality, but MNA-SF was better at 243 
predicting LOS. Van Bokhorst-de van der Schueren et al discussed in a recent 244 
systematic review of current nutrition screening tools for the hospital setting, that the 245 
MNA generally fairs better in older patients compared to the MUST, and that MUST 246 
is a not a good predictor of outcome in older patients4. Further, Soderstrom et al, 247 
showed in a large cohort of older people (n=1767) that the MNA is predictive of 248 
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mortality (a 50 month follow-up period) after taking into account confounding 249 
factors3. However, Vischer et al, failed to show a predictive effect of MNA-SF in 250 
hospitalised older patients with a heavy disease burden24. This is interesting as the 251 
patient group studied here also had a high disease burden (although this was not 252 
recorded as a ‘comorbidity/severity index’). The Vischer et al study was performed in 253 
a larger patient group (n=444), over a longer 4 year period24. They also observed 254 
that BMI was a significant predictor of mortality. In the data presented here BMI was 255 
found to be significantly lower in the mortality group, despite still being within a 256 
‘normal weight’ BMI category (by WHO and MUST). Estimation of FM and FMI by 257 
BIA was found to be significantly lower, whilst FFMI was similar (17 kg/m2). ROC 258 
curve analysis (Figure 2) found that both FM and FMI were significant predictors of 259 
mortality outcome (P=0.005), whereas BMI had a trend towards significance 260 
(P=0.062). This data may be supportive of a potential BMI or obesity paradox25, and 261 
is in-line with a study by Bouillanne et al, which showed a protective effect of FM as 262 
opposed to FFM with mortality in older hospital patients26. This may be viewed as 263 
unexpected as it has been assumed that FFM has a more important role. For 264 
example, the breakdown of FFM body protein tissue to fuel the acute phase stress 265 
response to illness and infection and the concomitant production of circulating acute 266 
phase proteins and glucose etc. We previously showed that high proportions of male 267 
patients had low/depleted FFMI values (and also skeletal muscle index-unpublished 268 
data), whilst having a normal BMI (e.g. 20-24.9 kg/m2)10. The low FFMI values may 269 
be due to the effects of complicated overlapping malnutrition, sarcopenia and 270 
cachexia states common in the frail older hospitalised patient. This is important to 271 
adequately address in clinical practice, however, the relationship of FM with clinical 272 
outcomes and mortality in this group requires further study and may relate to other 273 
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factors. Possible reasons for the observed phenomena may relate to the diverse 274 
function of the FM/adipose tissue organ, for example, acting as an energy resource 275 
during illness and potentially acting in a protein sparring manner; and/or due to other 276 
endocrine and immune functions of the tissue. 277 
Routine blood markers have been previously shown to indicate changes in relative 278 
nutritional status, inflammation and have prognostic abilities. In this study, albumin, 279 
CRP, the CRP-albumin ratio and urea were measured and related to clinical 280 
outcomes in patients. Albumin levels were found to be typically low across all 281 
patients (30.5±5.9 g/l), potentially indicating a combination of malnutrition and 282 
inflammation burden. However, there was no significant difference with patients 283 
grouped by mortality at 12 months (Table 1), or significant predictive ability by ROC 284 
curve analysis (Figure 3). Grouping patients by albumin classification of malnutrition 285 
(Table 3) showed that there were a greater proportion of people who died with lower 286 
albumin scores, with a trend for TMFFD and LOS to be higher and a highly 287 
significant relationship with CRP (lower albumin, higher CRP). There was also a 288 
significant correlation relationship between albumin and MNA-SF score (Figure 1). 289 
Furthermore, there were 7 patient deaths in hospital of which 6 had albumin data 290 
available (24.5±3.7 g/l), and was found to be significantly lower (P<0.05) than the 291 
patients who were alive at 12 months or those that died post hospital discharge. This 292 
is in-line with other observations that albumin is a known predictor of mortality14-16. 293 
Albumin may be an important measurable nutritional domain which should be 294 
considered in relation to inflammation burden and weight loss, despite recently being 295 
observed to not be related to body composition-related nutritional status27. Albumin 296 
levels are also utilised within clinically determining cachexia presence (along with 297 
weight loss, BMI, presence of inflammation etc.), and is a key component of the 298 
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GNRI9,12.  In particular, the GNRI has been shown to have good prognostic abilities 299 
including within a recent Egyptian study which found that the GNRI had better 300 
prognostic ability than the MNA28.  301 
CRP is another known prognostic indicator and CRP data was collected and 302 
assessed in patients (Table 1) as an indicator of inflammatory stress. Levels were 303 
clinically significant across the group indicating effects of illness, but there was no 304 
significant difference between patients grouped by mortality at 12 months.  ROC 305 
curve analysis confirmed that neither CRP nor the CRP-albumin albumin were 306 
significant predictors of mortality in this group.  307 
Finally, urea was significantly higher in the patients who died at 12 months (Table 1), 308 
but was found not to be a significant predictor of mortality outcome by ROC curve 309 
analysis. Increases in urea may be predictable in this setting indicating higher whole 310 
body protein catabolism, due to illness and associated inflammatory stress, and 311 
alterations in kidney function. Blood urea nitrogen has been observed to be an 312 
independent predictor of mortality outcome in different patient groups including in 313 
cardiovascular diseases and acute coronary syndromes29. Pan et al showed recently 314 
in older ICU patients that both albumin and urea act as independent and synergistic 315 
predictors of mortality30.    316 
Study limitations include the patient number which may have meant that some 317 
analyses were underpowered (e.g. ROC curve analysis of mortality prediction).  The 318 
lack of significant relationships with the specific blood markers (e.g. ROC curve 319 
analysis, Figure 3) is not surprising as circulating concentrations are highly variable 320 
(e.g. albumin and CRP) with many factors affecting them14-18,28. In addition, this was 321 
a single sample collection. The use of BIA and the Kyle equation for FFM estimation 322 
is discussed elsewhere as a potential limitation10. Furthermore, another criticism may 323 
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be the high heterogeneity of frail older people, but this study reflects ‘real-world’ 324 
medicine and chosen screening and assessment tools must be practically effective 325 
in this population.  326 
In conclusion, we previously showed discordance between MUST and MNA-SF risk 327 
categorisation in frail older hospital patients10. This paper suggests that discordance 328 
is not only theoretical but may have practical implications for outcome in this group. 329 
The MNA-SF is a simple tool and in combination with body composition 330 
measurements and blood markers may better categorise frail older patients with 331 
respects to their nutritional status and possible clinical outcomes, including mortality 332 
risk. Further research is necessary in larger patient cohorts as there are potential 333 
healthcare, clinical outcome and economic factors implicated. 334 
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Highlights  461 
 The standard routine tool used for malnutrition risk screening in the United 462 
Kingdom, the ‘MUST’, may lack diagnostic accuracy and predictive ability in 463 
determining mortality risk in frail older hospital patients. 464 
 The MNA-SF tool appears to be a more accurate tool in determining malnutrition 465 
risk and prediction of mortality risk in this patient group. 466 
 A potential BMI paradox is highlighted whereby mortality is greater in patients 467 
who have a normal range BMI compared to overweight.  468 
 The fat mass and fat mass index measurements may be predictive of mortality 469 
risk in this patient group and requires further study. 470 
 A combination of methods (e.g. the MNA-SF, body composition assessment and 471 
blood markers) may be clinically useful in determining nutritional 472 
status/malnutrition risk in this patient group and possible clinical outcomes, such 473 
as mortality.  474 
 475 
